Chat message

Slack / Private Message Drop, p.521 [SLACK_000735] · slack_pm:msg:05420

Date: 2021-02-17 12:11
Type: chat message · slack
recipient: Kristian G. Andersen, Edward C. Holmes, Andrew Rambaut
speaker: Robert F. Garry
Topics: Vaccines

Recipients on this medium are inferred from channel membership, not per-message addressing.

Yes - indeed that was my main concern - can humans recognize that epitope? Odds were good in favor, but not 100%. Good to see the data and yes - get the v.2 with Nelly, EeeK, "DorA", "DouG, Jr." and a few others into production asap. Relevant discussion after you left on the EBOV vaccine - seems that protection is rather short-livedtoo which explains the vaccinee infections, re-infections or recrudescence. Unless you stabilize those class I Viral Fusion Proteins it's hard to induce good neuts. EBOV good enough for ring vaccination, long term protection - not somuch unless you plan on vaccinating everyone against EBOV on a yearly basis.

Extracted statements

Rule-extracted, not adjudicated. The grade says what may be done with each one; read the document above before relying on any of them.

Statement	Grade	Attribution	Stance
Relevant discussion after you left on the EBOV vaccine - seems that protection is rather short-livedtoo which explains the vaccinee infections, re-infections or recrudescence.	needs context	uncertain explicit hedge	asserts

Statement

Grade

Attribution

Stance

Relevant discussion after you left on the EBOV vaccine - seems that protection is rather short-livedtoo which explains the vaccinee infections, re-infections or recrudescence.

needs context

uncertain explicit hedge

asserts

In context

A single line often inverts meaning once you see what it answers, so neighbouring messages are always shown.

2021-02-17 12:11 Robert F. Garry

Yes - indeed that was my main concern - can humans recognize that epitope? Odds were good in favor, but not 100%. Good to see the data and yes - get the v.2 with Nelly, EeeK, "DorA", "DouG, Jr." and a few others into production asap. Relevant discussion after you left on the EBOV vaccine - seems that protection is rather short-livedtoo which explains the vaccinee infections, re-infections or recrudescence. Unless you stabilize those class I Viral Fusion Proteins it's hard to induce good neuts. EBOV good enough for ring vaccination, long term protection - not somuch unless you plan on vaccinating everyone against EBOV on a yearly basis.

Full conversation →